Surgical Glue Market
Report ID: SQMIG35B2355
Report ID: SQMIG35B2355
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35B2355 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
117
|Figures:
77
Global Surgical Glue Market size was valued at USD 3.28 Billion in 2024 and is poised to grow from USD 3.5 Billion in 2025 to USD 5.94 Billion by 2033, growing at a CAGR of 6.83% during the forecast period (2026-2033).
The surgical glue market includes adhesives and sealants used to close skin and internal tissues and is important as these products reduce operating time, infection rates, improve wound aesthetic and function. The main drive is the trend towards minimally invasive and outpatient procedures that require fast, reliable closure without extensive suturing. Surgeons have turned to topical cyanoacrylates as well as advanced fibrin or synthetic sealants.
Historically, the surgical glue market outlook has progressed from early medical cyanoacrylates to commercial brands such as Dermabond and fibrin products such as Tisseel. Recent development has been focused on bioresorbable internal adhesives to address complex surgical need and regulatory acceptance.A key growth driver is ongoing material and formulation innovation that translates to clinical applicability, so when researchers create stronger, flexible and bioresorbable adhesives surgeons can replace sutures for many procedures and that drives broader adoption and higher market revenues. For example, stronger synthetic sealants enable laparoscopic anastomoses and faster skin closure in emergency departments, reducing procedure time, infection rates and length of stay in hospital and leading to demonstrable cost savings that drive hospital procurement. Growing elderly populations and parallel increasing healthcare access in Asia-Pacific are driving surgical volumes, offering opportunities for product differentiation, combination hemostatic-adhesives, and targeted reimbursement strategies and adoption.
AI is optimizing surgical adhesive formulation and application. AI analyzes material databases and predicts interactions between polymer blends, crosslinkers and biocompatible additives for formulation, allowing virtual screening and digital twin testing to reduce the need for physical trials. Application AI controls delivery through imaging and robotic control for accurate positioning and consistent curing, increasing reliability and reducing tissue trauma. There is a market desire for faster regulatory pathways and better outcomes. Real world examples include FDA cleared high viscosity tissue adhesives from Resivant Medical, which show renewed product innovation. Proximie demonstrates how AI can be embedded in operating rooms to deliver procedural intelligence.
Market snapshot - (2026-2033)
Global Market Size
USD 3.28 Billion
Largest Segment
Synthetic Surgical Glues
Fastest Growth
Natural Biological Glues
Growth Rate
6.83% CAGR
To get more insights on this market click here to Request a Free Sample Report
The global surgical glue market is segmented by product chemistry composition, application clinical area, end-user, distribution channel, and region. Based on product chemistry composition, the market is segmented into Synthetic Surgical Glues and Natural Biological Glues. Based on application clinical area, the market is segmented into General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Ophthalmic Surgery, Central Nervous System Surgery and Others. Based on end-user, the market is segmented into Hospitals & Clinics and Ambulatory Surgical Centers. Based on distribution channel, the market is segmented into Direct and Indirect. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per the surgical glue market analysis, the Synthetic Surgical Glues segment is leading the market due to predictable polymer chemistry, fast and controllable curing, and robust mechanical strength which clinicians favor to reliably achieve hemostasis and approximation of tissues in a variety of procedures. Scalability in manufacturing and longer shelf life reduce logistical barriers, while consistent regulatory pathways and robust clinical data drive hospital formulary adoption. These factors drive procurement preference, support supplier investment in formulation improvements and embed synthetic adhesives into standard surgical workflows.
However, the Natural Biological Glues category is predicted to have the largest surgical glue market share as demand increases for biologically compatible sealants in delicate and contaminated wounds, improvements in recombinant production reduce variability and the clinical enthusiasm for tissue regenerative properties. This adoption opens up new indications, supports customized formulations, and creates premium opportunities across surgical specialties.
According to the surgical glue market forecast, the Cardiovascular Surgery segment is anticipated to be the largest during the forecast period owing to the challenges of acute hemostasis and sealing in vascular procedures, where reliable adhesives can minimize bleeding, decrease operative time, and reduce the risk of reoperation, thus making the glue choice crucial. High clinical value and payer recognition for improved outcomes drive hospital procurement and specialized product development. As a result, manufacturers concentrate on cardiovascular indications, invest in targeted formulations and training and obtain clinical evidence that support adoption in complex cardiac and vascular interventions.
But Ophthalmic Surgery is showing the highest growth momentum as surgeons seek atraumatic, microscale adhesives for corneal and intraocular procedures, and advances in biocompatible clear formulations open new minimally invasive techniques. Regulatory approvals for ocular indications and rising patient demand for faster recovery are driving the adoption, leading to the expansion of niche product pipelines.
To get detailed segments analysis, Request a Free Sample Report
As per the surgical glue market regional forecast, North America held the largest market share in the market, owing to a combination of mature healthcare infrastructure, robust clinical research ecosystems, and concentrated industry presence. High investments from public and private sources in medical technologies support the swift adoption of advanced adhesive systems in both acute care and outpatient settings. Dense networks of leading hospitals and specialist clinicians generate clinical evidence and best practices, and well-established regulatory and reimbursement pathways enable commercialization. Local manufacturing capabilities and strategic supplier-healthcare provider partnerships guarantee dependable supply chains and tailored product portfolios. Strong academic industry collaboration also underpins continual product refinement and acceptance by clinicians.
U.S. Surgical Adhesive Market
The Surgical Glue sector in the United States highlights early clinical adoption with full surgical infrastructure, high research activity, and extensive specialty networks. Strong regulatory pathways and partnerships between suppliers and large hospitals generate strong clinical evidence and open market access. Innovation and broad availability across acute and ambulatory care settings are driven by reimbursement mechanisms and private sector investment . Strategic partnerships sustain clinician engagement and product refinement, and supply chain resilience .
Canada Surgical Glue Market
The Surgical Glue industry in Canada is characterized by a publicly funded healthcare system, centralized procurement processes and a focus on evidence-based adoption. Clinical evaluation and integration of adhesive technologies for various surgical procedures are driven by regional health authorities and tertiary hospitals. Health technology assessments and negotiated purchasing encourage cost-effective utilization while collaborations between suppliers and academic centers support local training initiatives and measured market expansion that balances safety, quality and sustainability.
Europe’s rapid development is driven by the increasing clinical focus on minimally invasive and tissue-preserving techniques, with established hospital systems and coordinated procurement frameworks. Regional centers of medical device innovation and manufacturing offer a solid foundation for product development and commercialization, and regulatory harmonization and reimbursement mechanisms in many jurisdictions facilitate market entry. Working across borders between clinicians and academic institutions generates comparative clinical evidence and practice guidelines that promote adoption. Public and private investment in upgrades to surgical capability and increasing surgeon familiarity and training programs accelerate penetration into both established and emerging markets. Strategic partnerships between multinational suppliers and local distributors provide customized product offerings and supply continuity, solidifying the continent as a major and diverse market.
Germany Surgical Glue Market
Surgical Glue Market in Germany has a strong manufacturing ecosystem and superior clinical infrastructure. Top medical technology clusters and industry-academic center collaboration contribute to product innovation and clinical evaluation. The decentralized procurement enables the regional hospitals to test and implement adhesive solutions in a range of surgical specialties. Robust clinician engagement, with supply chains to ensure regular availability, and continued integration into surgical practice at high quality standards.
UK Surgical Glue Market
The UK Surgical Glue Market is a fast-growing opportunity, driven by centralized procurement, innovation hubs and active clinical adoption. Pilot programs within public health systems and collaborations between industry and research institutions enable swift evaluation and scaling of adhesive technologies. Regulatory flexibility and targeted training programs promote broader acceptance by surgeons. Broad market penetration and quality are supported by dynamic distribution partnerships and a positive ecosystem for medical innovation.
France Surgical Glue Market
The Surgical Glue Market in France shows emerging momentum backed by strong clinical networks and regional centers of surgical excellence. Health authorities and hospital systems emphasize the need for evidence-based evaluation and prudent integration of adhesive solutions to complement established surgical protocols. Manufacturers' partnerships with academic institutions foster local research and training of clinicians. Centralized reimbursement assessment and negotiated procurement approaches promote measured adoption while preserving patient safety and cost effectiveness priorities for wider uptake
Asia Pacific is consolidating its position through a combination of expanding healthcare infrastructure, increasing clinical capacity and increasing local production capabilities. Governments and private investors are improving surgical facilities and encouraging the transfer of technology so that adhesive technologies are widely available in different care settings. Strategic partnerships between global suppliers and regional manufacturers accelerate localization and regulatory alignment of the products, and targeted training and demonstration programs increase confidence of clinicians. The region has advanced markets that provide high quality research and innovation, and these are complemented by rapid adoption in emerging markets, fueled by medical tourism and cost-conscious procurement. Policy reforms that improve regulatory efficiency and harmonized standards further reduce barriers to market entry, facilitating sustained regional integration.
Japan Surgical Glue Market
Surgical Glue Market in Japan is known for its high quality regulatory standards and significant investment in clinical research. Local manufacturers and research institutes are working with hospitals to enhance adhesive technologies tailored for particular surgical applications. Rigorous evaluation and training of clinicians is highlighted to facilitate integration into complex surgical workflows. The existing supply chains and partnerships with global suppliers enable product availability and focused innovation delivers solutions that meet local clinical preferences and quality expectations.
South Korean Surgical Glue Market
Surgical Adhesive Market South Korea has a vibrant medical innovation ecosystem, with cutting-edge hospital networks and agile manufacturing capabilities. Local companies join hands with foreign vendors in joint ventures to speed up technology transfer and product localization. Specialized clinical training programs help surgeons become more comfortable with adhesive solutions. Access is facilitated by efficient distribution channels and supportive regulatory pathways. Focus on quality, innovation and exports makes the market a regional hub for surgical adhesives
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Preference For Minimally Invasive Surgery
Advances In Bioadhesive Formulations
Stringent Regulatory Approval Requirements
High Cost Of Specialty Adhesives
Request Free Customization of this report to help us to meet your business objectives.
The surgical glue market is highly competitive with the presence of different global and local players. The key strategies followed by the players are the launch of advanced biocompatible and antimicrobial adhesives, expansion of regulatory approvals across regions, investment in R&D for rapid healing formulations, hospital partnership, acquisition of innovative wound care companies, and strengthening of distribution networks in emerging markets to increase market penetration and brand loyalty.
Top Player’s Company Profile
Recent Developments in the Surgical Glue Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global surgical glue market is primarily driven by the trend towards minimally invasive and outpatient procedures that require rapid, reliable tissue closure. Additionally, the market is driven by advancements in bioadhesive formulations that enhance biocompatibility, strength and degradability. However, stringent and variable regulatory approval requirements continue to be a major restraint, lengthening time to market and increasing development costs. North America continues to dominate the market due to mature healthcare infrastructure, robust clinical research and favourable reimbursement pathways. Synthetic surgical glues dominate the segment due to predictable polymer chemistry, rapid curing, strong clinical evidence and supply chain scalability, enabling suppliers to capitalize on growing procedural adoption.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 3.28 Billion |
| Market size value in 2033 | USD 5.94 Billion |
| Growth Rate | 6.83% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Surgical Glue Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Surgical Glue Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Surgical Glue Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Surgical Glue Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Surgical Glue Market size was valued at USD 3.28 Billion in 2024 and is poised to grow from USD 3.5 Billion in 2025 to USD 5.94 Billion by 2033, growing at a CAGR of 6.83% during the forecast period (2026-2033).
I can do that, but I need to verify recent company founding dates and developments to ensure both startups meet your rule (not established before 2019) and are real. Do you want me to look these up and use verified, up-to-date sources before I generate the two startup bullets? 'Baxter International', 'Johnson & Johnson', 'B. Braun SE', 'Medtronic', 'Stryker Corporation', 'CryoLife', 'Covera Health', 'Advance Medical Solutions Group', 'Sanofi', 'Pfizer', 'Adhezion Biomedical', 'Cohesion Technologies', 'Focal Inc', 'Ocular Therapeutix', 'Tissuemed', 'Vivostat', 'Genzyme Corporation', 'Mallinckrodt plc', 'Integra LifeSciences', 'Smith & Nephew'
Surgeons and patients increasingly prefer minimally invasive procedures because they reduce operative trauma and support faster recovery, which elevates demand for advanced closure technologies such as surgical glues. This preference encourages hospitals and clinics to stock and standardize use of adhesive solutions that complement endoscopic and laparoscopic approaches, prompting suppliers to develop formulations tailored to less invasive contexts. As clinical workflows shift, procurement policies and clinician training adapt to integrate glues more routinely, thereby sustaining market expansion through broader clinical acceptance.
Bioresorbable And Bioactive Adhesives: Development of bioresorbable and bioactive surgical glues is shifting product design toward adhesives that not only close tissues but actively support healing and reduce foreign-body response. Manufacturers are prioritizing materials that degrade predictably while releasing growth factors or promoting cell adhesion, enabling broader use in delicate tissues. Clinicians appreciate options that minimize long-term implant burden and complement regenerative strategies. This trend fosters collaboration between biomaterials scientists, surgeons, and suppliers to translate biologically interactive formulations from research into commercial surgical practice.
Why does North America Dominate the Global Surgical Glue Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
